XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements Of Cash Flows - USD ($)
9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Operating Activities    
Net income (loss) $ 11,250,804 $ (2,453,037)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 5,727,708 6,176,173
Impairment of producing properties 11,862 45,855
Provision for deferred income taxes 207,000 (1,117,000)
Gain from leasing fee mineral acreage (449,053) (316,541)
Proceeds from leasing fee mineral acreage 545,920 334,938
Net (gain) loss on sales of assets (865,035) (136,596)
Directors' deferred compensation expense 147,298 167,425
Total (gain) loss on derivative contracts 12,534,464 8,089,662
Cash receipts (payments) on settled derivative contracts (1,215,245) (688,807)
Restricted stock awards 1,219,047 542,674
Other 55,653 72,126
Cash provided (used) by changes in assets and liabilities:    
Natural gas, oil and NGL sales receivables (5,351,575) (2,134,395)
Other current assets (78,262) (89,957)
Accounts payable (251,059) 209,014
Income taxes receivable 1,553,526 1,425,471
Other non-current assets (393,492) 87,065
Income taxes payable (334,050)  
Accrued liabilities 23,463 26,263
Total adjustments 13,088,170 12,693,370
Net cash provided by operating activities 24,338,974 10,240,333
Investing Activities    
Capital expenditures (351,524) (696,759)
Acquisition of minerals and overriding royalty interests (29,872,407) (19,337,265)
Net proceeds from sales of assets 7,852,389 533,371
Net cash provided (used) by investing activities (22,371,542) (19,500,653)
Financing Activities    
Borrowings under Credit Facility 14,300,000  
Payments of loan principal (3,500,000) (8,850,000)
Net proceeds from equity issuance 4,670,112 11,088,858
Cash receipts from (payments on) off-market derivative contracts (13,845,596)  
Purchases of treasury stock   (2,741)
Payments of dividends (1,541,177) (757,692)
Net cash provided (used) by financing activities 83,339 1,478,425
Increase (decrease) in cash and cash equivalents 2,050,771 (7,781,895)
Cash and cash equivalents at beginning of period 2,438,511 10,690,395
Cash and cash equivalents at end of period 4,489,282 2,908,500
Supplemental Schedule of Noncash Investing and Financing Activities:    
Gross additions to properties and equipment 33,431,875 23,794,178
Value of shares used for acquisitions (3,510,001) (3,718,000)
Net (increase) decrease in accounts payable for properties and equipment additions 302,057 (42,154)
Capital expenditures and acquisitions $ 30,223,931 $ 20,034,024